FINAL AGENDA JUST RELEASED



http://www.chimolecularmed.com/04gbs.asp
  

Register Today                                               Download Brochure

The current economic climate presents significant challenges for biotech and pharma. 
The cost of drug development is enormous, and the risk of failure is great. The Business
Strategies conference will explore ways to structure your business to maximize potential.

HEAR INDUSTRY LEADER INSIGHT INTO:

  • Business models that are viable in the current biotech climate

  • Blockbuster strategy - does it make sense?

  • Reducing late-stage failure of drug compounds

  • R&D resources: in-house vs. outsource?
    What areas are considered too valuable to outsource?


  • Evaluating technology issues around integration,
    implementation, scale-up


  • Knowledge Management

  • Partnering with pharma - what are they looking for from
    biotech that will add value?

  • Licensing and deal making

  • Partnership structures of the future - structuring
    biotech collaborations


  • Patent strategies to protect your IP investment

OVER THIRTY PRESENTATIONS FROM TOP
PHARMACEUTICAL AND BIOTECH LEADERS

Leaders From The           
Following Organizations
Will be Presenting:         

Aventis

Pfizer

Merck & Co.

Veridex

Acadia Pharma

Hoffman La-Roche

Affymetrix

SG Cowen Securities

Tufts Center for the
Study of Drug
Development

Millennium
Pharmaceuticals

Chiron Corporation

NIH

Plus Many More!

 Register For Four Days And Attend
 The Emerging Company
 Partnering Opening Forum 
 March 23, 2004

Hear 40 early stage companies showcasing what  sets them apart from competitors and
what types of  deals they are interested in.  Plus thought leader 
insights from the
following keynotes:

State of The Biotechnology Industry

Mr. G. Steven Burrill
Chief Executive Officer
Burrill & Co.                             

Emerging Company Alliances:
Learning from History, but
Finding
a Unique Way Forward

Mr. Mark G. Edwards
Managing Director and Founder 
Recombinant Capital

SPECIAL BENEFITS WITH THE FOUR DAY PASS

 Purchase a Four Day Pass for $1545 commercial or $840
 academic and your registration will provide you:
  • Access to over 130 Presentations
  • All Five Speaker Abstract CDs, one for
    each of the Five conferences
  • Four days of Networking Opportunities
  • Access to the Opening Emerging Company
    Partnering Forum

  Plus Reserve Your Room At the San Francisco Marriott
   (Only $159 Per Night) and Save an Additional $150 off Your 
  Attendance Fee!!
  
Click Here For Details 


For more information in this event or details on the other four conferences at
Molecular Medicine Tri-Conference visit:
www.chiMolecularMed.com 


This email has been circulated by BioPortfolio Ltd on behalf of the Cambridge Healthtech Institute. As a registered user of the BioPortfolio web sites, you were selected to receive this message in the genuine belief that it would be of interest to you.

Subscriber information:
To unsubscribe, email: bioportfolio-signoff-request@peach.ease.lsoft.com WITH NO SUBJECT.  The system will automatically remove your email address from the list based on your email address.  If your email has changed please email peter.barfoot@bioportfolio.com with a list of your email address and we will manually unsubscribe for you.  Thank you for your understanding.

To subscribe for the BioPortfolio Bulletin in HTML, email:
bioportfolio-subscribe-request@peach.ease.lsoft.com

Disclaimer:
BioPortfolio Limited and its agents used their best efforts in collecting and preparing the information published herein. However, BioPortfolio does not assume, and hereby disclaims, any and all liability for any loss or damage caused by errors, whether such errors resulted from negligence, accident, or other causes. All rights reserved. ©2004 BioPortfolio Limited